Skip to main content
Equibles

MANKIND · Mankind Pharma Limited · Financials

Use MANKIND with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MANKIND.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
2,640.00 INR +1.40 (+0.05%) At close · Nov 13
Rebalance outlook locked
Market Cap
1.09T INR
Shares
413.05M
Volume · Nov 13 494.74K Avg daily vol (3M) 573.31K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
142.78B +17%
FY2026 Revenue FY2023–FY2026
Net Income
19.13B -3.7%
FY2026 Net Income FY2023–FY2026
Operating Cash Flow
31.21B +29.3%
FY2026 Operating Cash Flow FY2023–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023
INR 153.79B 142.78B 122.07B 103.35B 87.49B
INR 9.07B 8.86B 6.21B 3.98B 3.26B
INR 5.14B 6.39B 4.29B 335.32M 444.69M
INR 6.03B 3.95B 5.1B 4.58B 3.62B
INR 22.49B 19.13B 19.86B 19.13B 12.82B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2026: 412.7M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.